Cargando…
Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils
Alzheimer’s disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer’s disease, tho...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794565/ https://www.ncbi.nlm.nih.gov/pubmed/33420184 http://dx.doi.org/10.1038/s41598-020-80042-5 |
_version_ | 1783634239346966528 |
---|---|
author | Scherpelz, Kathryn P. Wang, Songlin Pytel, Peter Madhurapantula, Rama S. Srivastava, Atul K. Sachleben, Joseph R. Orgel, Joseph Ishii, Yoshitaka Meredith, Stephen C. |
author_facet | Scherpelz, Kathryn P. Wang, Songlin Pytel, Peter Madhurapantula, Rama S. Srivastava, Atul K. Sachleben, Joseph R. Orgel, Joseph Ishii, Yoshitaka Meredith, Stephen C. |
author_sort | Scherpelz, Kathryn P. |
collection | PubMed |
description | Alzheimer’s disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer’s disease, though it sometimes occurs in the absence of neuritic plaques, as AD also occurs without accompanying CAA. Although neuritic plaques and vascular deposits have similar protein compositions, one of the characteristic features of amyloids is polymorphism, i.e., the ability of a single pure peptide to adopt multiple conformations in fibrils, depending on fibrillization conditions. For this reason, we asked whether the Aβ fibrils in neuritic plaques differed structurally from those in cerebral blood vessels. To address this question, we used seeding techniques, starting with amyloid-enriched material from either brain parenchyma or cerebral blood vessels (using meninges as the source). These amyloid-enriched preparations were then added to fresh, disaggregated solutions of Aβ to make replicate fibrils, as described elsewhere. Such fibrils were then studied by solid-state NMR, fiber X-ray diffraction, and other biophysical techniques. We observed chemical shift differences between parenchymal vs. vascular-seeded replicate fibrils in select sites (in particular, Ala2, Phe4, Val12, and Gln15 side chains) in two-dimensional (13)C-(13)C correlation solid-state NMR spectra, strongly indicating structural differences at these sites. X-ray diffraction studies also indicated that vascular-seeded fibrils displayed greater order than parenchyma-seeded fibrils in the “side-chain dimension” (~ 10 Å reflection), though the “hydrogen-bond dimensions” (~ 5 Å reflection) were alike. These results indicate that the different nucleation conditions at two sites in the brain, parenchyma and blood vessels, affect the fibril products that get formed at each site, possibly leading to distinct pathophysiological outcomes. |
format | Online Article Text |
id | pubmed-7794565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-77945652021-01-12 Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils Scherpelz, Kathryn P. Wang, Songlin Pytel, Peter Madhurapantula, Rama S. Srivastava, Atul K. Sachleben, Joseph R. Orgel, Joseph Ishii, Yoshitaka Meredith, Stephen C. Sci Rep Article Alzheimer’s disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer’s disease, though it sometimes occurs in the absence of neuritic plaques, as AD also occurs without accompanying CAA. Although neuritic plaques and vascular deposits have similar protein compositions, one of the characteristic features of amyloids is polymorphism, i.e., the ability of a single pure peptide to adopt multiple conformations in fibrils, depending on fibrillization conditions. For this reason, we asked whether the Aβ fibrils in neuritic plaques differed structurally from those in cerebral blood vessels. To address this question, we used seeding techniques, starting with amyloid-enriched material from either brain parenchyma or cerebral blood vessels (using meninges as the source). These amyloid-enriched preparations were then added to fresh, disaggregated solutions of Aβ to make replicate fibrils, as described elsewhere. Such fibrils were then studied by solid-state NMR, fiber X-ray diffraction, and other biophysical techniques. We observed chemical shift differences between parenchymal vs. vascular-seeded replicate fibrils in select sites (in particular, Ala2, Phe4, Val12, and Gln15 side chains) in two-dimensional (13)C-(13)C correlation solid-state NMR spectra, strongly indicating structural differences at these sites. X-ray diffraction studies also indicated that vascular-seeded fibrils displayed greater order than parenchyma-seeded fibrils in the “side-chain dimension” (~ 10 Å reflection), though the “hydrogen-bond dimensions” (~ 5 Å reflection) were alike. These results indicate that the different nucleation conditions at two sites in the brain, parenchyma and blood vessels, affect the fibril products that get formed at each site, possibly leading to distinct pathophysiological outcomes. Nature Publishing Group UK 2021-01-08 /pmc/articles/PMC7794565/ /pubmed/33420184 http://dx.doi.org/10.1038/s41598-020-80042-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Scherpelz, Kathryn P. Wang, Songlin Pytel, Peter Madhurapantula, Rama S. Srivastava, Atul K. Sachleben, Joseph R. Orgel, Joseph Ishii, Yoshitaka Meredith, Stephen C. Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils |
title | Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils |
title_full | Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils |
title_fullStr | Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils |
title_full_unstemmed | Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils |
title_short | Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils |
title_sort | atomic-level differences between brain parenchymal- and cerebrovascular-seeded aβ fibrils |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794565/ https://www.ncbi.nlm.nih.gov/pubmed/33420184 http://dx.doi.org/10.1038/s41598-020-80042-5 |
work_keys_str_mv | AT scherpelzkathrynp atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT wangsonglin atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT pytelpeter atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT madhurapantularamas atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT srivastavaatulk atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT sachlebenjosephr atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT orgeljoseph atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT ishiiyoshitaka atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils AT meredithstephenc atomicleveldifferencesbetweenbrainparenchymalandcerebrovascularseededabfibrils |